NeoStem, Inc. announces it has been added to the broad-market Russell 3000 Index with Russell Investments’ reconstitution of its comprehensive set of U.S. and global equity indexes effective June 25th. […]
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China, announces a number of business updates. […]
NeoStem, Inc (AMEX: NBS)
Interview with Dr. Robin Smith, Chairman & CEO […]
NeoStem, Inc. announces it was advised that its Suzhou Erye Pharmaceutical subsidiary (“Erye”) received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
